Reply from Authors re: Prokar Dasgupta. Volume Matters: Bladder Injections of Botulinum Toxin Type A. Eur Urol 2012;61:1185-6 (Englisch)
- Neue Suche nach: Coelho, A.
- Neue Suche nach: Cruz, F.
- Neue Suche nach: Cruz, C. D.
- Neue Suche nach: Avelino, A.
- Neue Suche nach: Coelho, A.
- Neue Suche nach: Cruz, F.
- Neue Suche nach: Cruz, C. D.
- Neue Suche nach: Avelino, A.
In:
EUROPEAN UROLOGY
;
61
, 6
;
1186-1187
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Reply from Authors re: Prokar Dasgupta. Volume Matters: Bladder Injections of Botulinum Toxin Type A. Eur Urol 2012;61:1185-6
-
Beteiligte:Coelho, A. ( Autor:in ) / Cruz, F. ( Autor:in ) / Cruz, C. D. ( Autor:in ) / Avelino, A. ( Autor:in )
-
Erschienen in:EUROPEAN UROLOGY ; 61, 6 ; 1186-1187
-
Verlag:
- Neue Suche nach: ELSEVIER SCIENCE B.V., AMSTERDAM
-
Erscheinungsdatum:01.01.2012
-
Format / Umfang:2 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.6
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.6 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 61, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1079
-
International Variation in Prostate Cancer Incidence and Mortality RatesCenter, Melissa M. / Jemal, Ahmedin / Lortet-Tieulent, Joannie / Ward, Elizabeth / Ferlay, Jacques / Brawley, Otis / Bray, Freddie et al. | 2012
- 1093
-
Prostate Cancer Epidemic in Sight?Schroder, F. H. / Roobol, M. J. et al. | 2012
- 1096
-
High-Risk Prostate Cancer: From Definition to Contemporary ManagementBastian, Patrick J. / Boorjian, Stephen A. / Bossi, Alberto / Briganti, Alberto / Heidenreich, Axel / Freedland, Stephen J. / Montorsi, Francesco / Roach, Mack / Schröder, Fritz / van Poppel, Hein et al. | 2012
- 1107
-
Thwarting High-risk Prostate Cancer: The Right Treatments for the Right PatientsCooperberg, M. R. et al. | 2012
- 1110
-
Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized TrialLoeb, Stacy / van den Heuvel, Suzanne / Zhu, Xiaoye / Bangma, Chris H. / Schröder, Fritz H. / Roobol, Monique J. et al. | 2012
- 1115
-
To Biopsy or Not to Biopsy-Thou Shall Think TwiceZlotta, A. R. / Nam, R. K. et al. | 2012
- 1117
-
Reply from Authors re: Alexandre R. Zlotta, Robert K. Nam. To Biopsy or Not to Biopsy-Thou Shall Think Twice. Eur Urol 2012;61:1115-7Loeb, S. / van den Heuvel, S. / Zhu, X. / Bangma, C. H. / Schroder, F. H. / Roobol, M. J. et al. | 2012
- 1119
-
Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous ThromboembolismHu, J. C. / Williams, S. B. / O'Malley, A. J. / Smith, M. R. / Nguyen, P. L. / Keating, N. L. et al. | 2012
- 1129
-
Androgen Deprivation Therapy for Localized and Nonmetastatic Prostate Cancer: Too Much of a Good Thing?Konijeti, Ramdev / Kibel, Adam S. et al. | 2012
- 1131
-
Reply from Authors re: Ramdev Konijeti, Adam S. Kibel. Androgen Deprivation Therapy for Localized and Nonmetastatic Prostate Cancer: Too Much of a Good Thing? Eur Urol 2012;61:1129–30Keating, Nancy L. / Smith, Matthew R. / Hu, Jim C. et al. | 2012
- 1132
-
Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node DissectionBriganti, A. / Abdollah, F. / Nini, A. / Suardi, N. / Gallina, A. / Capitanio, U. / Bianchi, M. / Tutolo, M. / Passoni, N. M. / Salonia, A. et al. | 2012
- 1139
-
Nodal Staging in Prostate Cancer: Still an Unresolved IssueJoniau, S. / Van den Bergh, L. / Peeters, C. / Haustermans, K. / Spahn, M. et al. | 2012
- 1142
-
Laparoscopic Versus Open Nephroureterectomy for the Treatment of Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Cumulative Analysis of Comparative StudiesNi, Shaobin / Tao, Weiyang / Chen, Qiyin / Liu, Lianxin / Jiang, Hongchi / Hu, Hailong / Han, Ruifa / Wang, Chunyang et al. | 2012
- 1154
-
Is There Currently Enough Evidence To Assess Whether Laparoscopic Nephroureterectomy Is Safe to Treat Urothelial Carcinoma of the Upper Urinary Tract?Rouprêt, Morgan et al. | 2012
- 1156
-
Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-UpOlweny, Ephrem O. / Park, Samuel K. / Tan, Yung K. / Best, Sara L. / Trimmer, Clayton / Cadeddu, Jeffrey A. et al. | 2012
- 1162
-
Is Radiofrequency Ablation for Small Kidney Tumors Ready for Prime Time?Goh, Alvin C. / Gill, Inderbir S. et al. | 2012
- 1163
-
Reply from Authors re: Alvin C. Goh, Inderbir S. Gill. Is Radiofrequency Ablation for Small Kidney Tumors Ready for Prime Time? Eur Urol 2012;61:1162-3.Olweny, E. O. / Cadeddu, J. A. et al. | 2012
- 1165
-
Photoselective Vaporization of the Prostate with GreenLight 120-W Laser Compared with Monopolar Transurethral Resection of the Prostate: A Multicenter Randomized Controlled Trialfor, t. R. / Lukacs, B. / Loeffler, J. / Bruyere, F. / Blanchet, P. / Gelet, A. / Coloby, P. / De la Taille, A. / Lemaire, P. / Baron, J. C. et al. | 2012
- 1174
-
After Three Randomised Controlled Trials Comparing 120-W High-Performance-System Potassium-Titanyl-Phosphate Laser Vaporisation to Transurethral Resection of the Prostate (TURP), Is This Procedure Finally First-Line, Outdated, or Still Not Surpassing TURP?Madersbacher, Stephan et al. | 2012
- 1176
-
Reply from Authors re: Stephan Madersbacher. After Three Randomised Controlled Trials Comparing 120-W High-Performance-System Potassium-Titanyl-Phosphate Laser Vaporisation to Transurethral Resection of the Prostate (TURP), Is This Procedure Finally First-Line, Outdated, or Still Not Surpassing TURP? Eur Urol 2012;61:1174–6Cornu, Jean-Nicolas / Vicaut, Eric / Aout, Mounir / Lukacs, Bertrand et al. | 2012
- 1178
-
Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin ActionCoelho, A. / Cruz, F. / Cruz, C. D. / Avelino, A. et al. | 2012
- 1185
-
Volume Matters: Bladder Injections of Botulinum Toxin Type ADasgupta, Prokar et al. | 2012
- 1186
-
Reply from Authors re: Prokar Dasgupta. Volume Matters: Bladder Injections of Botulinum Toxin Type A. Eur Urol 2012;61:1185-6Coelho, A. / Cruz, F. / Cruz, C. D. / Avelino, A. et al. | 2012
- 1188
-
Percutaneous Nephrolithotomy in the United Kingdom: Results of a Prospective Data Registryfor, t. B. / Armitage, J. N. / Irving, S. O. / Burgess, N. A. et al. | 2012
- 1194
-
The Time Is Now-the Ability Is Yoursde la Rosette, J. et al. | 2012
- 1195
-
Reply from Authors re: Jean de la Rosette. The Time Is Now-the Ability Is Yours. Eur Urol 2012;61:1194-5for, t. B. / Armitage, J. N. / Irving, S. O. / Burgess, N. A. et al. | 2012
- 1197
-
European Urology: An American PerspectiveFreedland, Stephen J. et al. | 2012
- 1199
-
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder Tumor ChecklistPan, D. / Soloway, M. S. et al. | 2012
- 1204
-
Salvage Cryoablation for Locally Recurrent Prostate Cancer Following Primary RadiotherapyMouraviev, V. / Spiess, P. E. / Jones, J. S. et al. | 2012
- 1212
-
The Contemporary Role of Chemotherapy for Advanced Testis Cancer: A Systematic Review of the LiteratureCalabro, F. / Albers, P. / Bokemeyer, C. / Martin, C. / Einhorn, L. H. / Horwich, A. / Krege, S. / Schmoll, H. J. / Sternberg, C. N. / Daugaard, G. et al. | 2012
- 1222
-
Technical Refinement and Learning Curve for Attenuating Neurapraxia During Robotic-Assisted Radical Prostatectomy to Improve Sexual FunctionAlemozaffar, Mehrdad / Duclos, Antoine / Hevelone, Nathanael D. / Lipsitz, Stuart R. / Borza, Tudor / Yu, Hua-Yin / Kowalczyk, Keith J. / Hu, Jim C. et al. | 2012
- 1229
-
Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancerthe, N. U. / Rosenblatt, R. / Sherif, A. / Rintala, E. / Wahlqvist, R. / Ullen, A. / Nilsson, S. / Malmstrom, P. U. et al. | 2012
- 1239
-
Comparative Analysis of Outcomes and Costs Following Open Radical Cystectomy Versus Robot-Assisted Laparoscopic Radical Cystectomy: Results From the US Nationwide Inpatient SampleYu, H. y. / Hevelone, N. D. / Lipsitz, S. R. / Kowalczyk, K. J. / Nguyen, P. L. / Choueiri, T. K. / Kibel, A. S. / Hu, J. C. et al. | 2012
- 1245
-
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic MarkersKandimalla, Raju / van Tilborg, Angela A.G. / Kompier, Lucie C. / Stumpel, Dominique J.P.M. / Stam, Ronald W. / Bangma, Chris H. / Zwarthoff, Ellen C. et al. | 2012
- 1257
-
Robotic Versus Laparoscopic Partial Nephrectomy for Complex Tumors: Comparison of Perioperative OutcomesLong, Jean-Alexandre / Yakoubi, Rachid / Lee, Byron / Guillotreau, Julien / Autorino, Riccardo / Laydner, Humberto / Eyraud, Remi / Stein, Robert J. / Kaouk, Jihad H. / Haber, Georges-Pascal et al. | 2012
- 1263
-
Re: Hedgehog/Wnt Feedback Supports Regenerative Proliferation of Epithelial Stem Cells in BladderVaegler, M. / Schenke-Layland, K. / Stenzl, A. et al. | 2012
- 1264
-
Re: Alkaline Citrate Reduces Stone Recurrence and Regrowth After Shockwave Lithotripsy and Percutaneous NephrolithotomyTiselius, Hans-Göran et al. | 2012
- 1264
-
Re: Baseline Prostate-Specific Antigen Testing at a Young AgeHekal, I. A. et al. | 2012
- 1265
-
Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-blind, Placebo-controlled TrialTombal, Bertrand / Lecouvet, Frederic et al. | 2012
- 1266
-
Re: Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Studyvan der Poel, Henk G. et al. | 2012
- 1267
-
Re: Can a Durable Disease-Free Survival be Achieved with Surgical Resection in Patients with Pathological Node Positive Renal Cell Carcinoma?Terrone, C. et al. | 2012
- 1269
-
Congress Calendar| 2012
- e53
-
Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378-84Orsola, A. / de Torres, I. / Morote, J. et al. | 2012
- e55
-
Reply to Anna Orsola, Ines de Torres and Juan Morote's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012:61:378-84van Rhijn, B. W. / van der Kwast, T. H. / Jewett, M. A. / Zlotta, A. R. et al. | 2012
- e55
-
Reply to Anna Orsola, Inés de Torres and Juan Morote's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012:61:378–84van Rhijn, Bas W.G. / van der Kwast, Theo H. / Jewett, Michael A.S. / Zlotta, Alexandre R. et al. | 2012
- e62
-
Acknowledgement to Reviewers| 2012
- i
-
Editorial Board| 2012
- iii
-
Award pages| 2012
-
Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification. Eur Urol. In press. DOI:10.1016/j.eururo.2012.01.019Tsuzuki, T. / Sassa, N. / Gotoh, M. et al. | 2012
-
Re: Jens J. Rassweiler, Michael Müller, Markus Fangerau, et al. iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience. Eur Urol 2012;61:628–31Mandal, Swarnendu / Goel, Apul / Gupta, Dheeraj Kumar et al. | 2012
-
Reply to Swarnendu Mandal, Apul Goel and Dheeraj Kumar Gupta's Letter to the Editor re: Jens J. Rassweiler, Michael Muller, Markus Fangerau, et al. iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience. Eur Urol 2012;61:628-31Rassweiler, J. et al. | 2012
-
Reply to Swarnendu Mandal, Apul Goel and Dheeraj Kumar Gupta's Letter to the Editor re: Jens J. Rassweiler, Michael Müller, Markus Fangerau, et al. iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience. Eur Urol 2012;61:628–31Rassweiler, Jens et al. | 2012
-
Reply to Erik B. Cornel's Letter to the Editor re: Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, et al. Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer. Eur Urol 2012;61:11-25Pagliarulo, V. / Mottet, N. / Schroder, F. H. et al. | 2012
-
Contents| 2012
-
Re: Jens J. Rassweiler, Michael Muller, Markus Fangerau, et al. iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience. Eur Urol 2012;61:628-31Mandal, S. / Goel, A. / Gupta, D. K. et al. | 2012
-
Re: Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, et al. Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer. Eur Urol 2012;61:11–25Cornel, Erik B. et al. | 2012